Cellbox Labs

Riga, Latvia Founded: 2020 • Age: 6 yrs
Organ-on-chip platform is provided for drug discovery and development.
Annual revenue $394,120 Latest available
Total funding $1.0M 2 rounds
Employees 10 Tracked headcount
Investors 2 Known backers
Products 3 Services tracked
Competitors 10 Brand Intelligence

About Cellbox Labs

Cellbox Labs is a company based in Riga (Latvia) founded in 2020. Cellbox Labs has raised $1.01 million across 2 funding rounds from investors including LatBAN and Buildit. The company has 10 employees as of December 31, 2023. Cellbox Labs offers products and services including Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model. Cellbox Labs operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others.

  • Headquarter Riga, Latvia
  • Employees 10 as on 31 Dec, 2023
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Cellboxlab
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $394.12 K (USD)
    12
    as on Dec 31, 2023
  • Net Profit
    -$101.94 K (USD)
    -215
    as on Dec 31, 2023
  • EBITDA
    Not available
  • Total Equity Funding
    $1.01 M (USD)

    in 2 rounds

  • Latest Funding Round
    $3.85 M (USD), Grant

    Aug 08, 2025

  • Investors
    LatBAN

    & 1 more

  • Employee Count
    10

    as on Dec 31, 2023

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Cellbox Labs

Cellbox Labs offers a comprehensive portfolio of products and services, including Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model.

Product name locked
Category locked
Primary

Hardware-software system for precise drug testing and experiment design.

Product name locked
Category locked
Locked

Platform accelerating research on gut-brain interactions for drug development.

Product name locked
Category locked
Locked

Tool evaluating medication effects on intestinal stem cells in simulated environments.

People of Cellbox Labs

Headcount 1-10
Employee Profiles 1
Employee Profiles
People
Roberts Rimsa
CTO & Co-founder

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Cellbox Labs

Cellbox Labs has successfully raised a total of $1.01M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $3.85 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in Cellbox Labs

Cellbox Labs has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LatBAN and Buildit.

All
Venture Fund
Investor Description Founded Year Domain Location
IOT startups are accelerated by Buildit in Latvia's ecosystem.
Locked Locked Locked
Angel investors are connected with businesses seeking funding.
Locked Locked Locked
Premium access

Investor details for Cellbox Labs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Cellbox Labs

Investments
Premium access

Investment portfolio details for Cellbox Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Cellbox Labs

Premium access

Detailed financials for Cellbox Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Cellbox Labs Comparisons

Cellbox Labs Primary company
Description
Organ-on-chip platform is provided for drug discovery and de...
Location
Riga, Latvia
Founded Year
2020
Annual Revenue
$394.12 K (USD)
Net Profit
-$101.94 K (USD)
EBITDA
Not available
Employees
10
As of 2023
Premium access

Peer comparison for Cellbox Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Cellbox Labs

Cellbox Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of in vitro models for drug development
Locked Locked Locked
Organ-on-a-chip platforms are developed for drug discovery applications.
Locked Locked Locked
Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement.
Locked Locked Locked
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
Locked Locked Locked
Small human tissue segments are generated in microfluidic chips.
Locked Locked Locked
Microfluidic devices are developed for industrial applications and brain-on-a-chip models.
Premium access

Detailed competitors of Cellbox Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Cellbox Labs

Premium access

Complete news archive for Cellbox Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cellbox Labs

Cellbox Labs was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Cellbox Labs is headquartered in Riga, Latvia.

Cellbox Labs is a funded company, having raised a total of $1.01M across 2 funding rounds to date.

As of Dec 31, 2023, the latest employee count at Cellbox Labs is 10.

Annual revenue of Cellbox Labs is $394.12K as on Dec 31, 2023.

Cellbox Labs offers Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, Primary Cell Gut-on-Chip Model while focusing on life sciences, life sciences platforms and tools, instruments, microfluidics, and organ on a chip. Provider of organ-on-chip platform for drug discovery and development. Delivering reliable solutions, it emphasizes quality, efficiency, and meeting diverse client needs.

Cellbox Labs's top competitors include Emulate, CN Bio and Nortis.

Cellbox Labs offers Vascularized Organ-on-Chip Platform, Gut-Brain-Axis-on-Chip, and Primary Cell Gut-on-Chip Model.

Cellbox Labs has 2 investors. Key investors include LatBAN, and Buildit.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available